Universal Brain Expands Executive Team to Accelerate Precision Psychiatry
PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- Universal Brain, developer of a neuroscience-based personalized treatment and diagnostic platform pioneering precision psychiatry, today announced the expansion of its executive team. The company, which recently closed a $3.2 million seed round, will leverage the key additions to its executive team to accelerate the development and rollout of its comprehensive platform to aid the diagnosis and treatment of depression and other mental health conditions.
- PALO ALTO, Calif., April 3, 2024 /PRNewswire/ -- Universal Brain , developer of a neuroscience-based personalized treatment and diagnostic platform pioneering precision psychiatry, today announced the expansion of its executive team.
- Universal Brain is developing the first and only platform to deliver objective, industry-defining measures to better understand and treat psychiatric conditions.
- By objectively measuring profiles of brain function, Universal Brain will reduce heterogeneity to improve precision in identification and development of more personalized treatments.
- "Their highly regarded expertise in their respective disciplines paired with a shared vision of advancing precision psychiatry through the use of objective data will be invaluable as we bring the Universal Brain platform to market."